ArticleTherapeutic advances in neurological disorders2021

Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial.

Alasdair J Coles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.